Government

REUTERS  by James Harding Giahyue                                                                                     Dec. 20, 2014

MONROVIA--Turnout for Liberian parliamentary elections on Saturday appeared to be low as concerns about Ebola kept many voters at home.

Polling stations were largely empty after voting began at 8 a.m. (3.00 a.m. ET) in the seafront capital Monrovia, with voters occasionally drifting in, despite precautions put in place by the National Elections Commission (NEC).

Staff with temperature guns at polling stations checked voters for any signs of the hemorrhagic fever, which is spread via bodily fluids. Voters were obliged to wash their hands with chlorine solution, to stand at least three feet apart in the queue, and bring their own pens to mark the ballot paper, officials said.

Read complete story.

REUTERS                                                                                                 NOV. 20, 2014
By Sarah N. Lynch

U.S. regulators on Thursday suspended trading in four small over-the-counter stocks of companies that they said have been touting the development of products to prevent or treat the Ebola virus, and warned investors to beware of similar scams.

The Securities and Exchange Commission said it had suspended trading in the shares of New York-based Bravo Enterprises Ltd, California-based Immunotech Laboratories Inc, Canada-based Myriad Interactive Media Inc and Wholehealth Products Inc, which is also located in California.

The SEC also issued a warning that "con artists" may be soliciting investors and claiming to be developing treatments or medicine to prevent the deadly virus.

Read complete story

http://www.reuters.com/article/2014/11/20/us-sec-ebola-scams-idUSKCN0J41V820141120

THE HILL                                                          Nov. 12, 2014
Commentary by Claire Pomeroy, M.D., M.B.A, President of the Albert and Mary Lasker Foundation.

...Without a commitment by Congress to fund basic medical research, the lives of millions are put at risk, along with the nation’s economic and national security. Outbreaks of deadly viruses – including AIDS or Ebola – have shown us the costs of not remaining vigilant.

  So how much funding is enough? It’s time for us to have that national conversation once again. We do not know what the superbugs of tomorrow will look like. But we do know that novel pathogens will emerge or existing ones will mutate, and that as global travel and migration inexorably increase, disease knows no border. It is time for us to stop chasing at AIDS and Ebola from behind, and take stock of our capacity to commit.

NEW YORK TIMES                                                 Oct. 18, 2014

By MICHAEL D. SHEAR and MARK LANDLER

WASHINGTON — Beneath the calming reassurance that President Obama has repeatedly offered during the Ebola crisis, there is a deepening frustration, even anger, with how the government has handled key elements of the response.

Those frustrations spilled over when Mr. Obama convened his top aides in the Cabinet room after canceling his schedule on Wednesday. Medical officials were providing information that later turned out to be wrong. Guidance to local health teams was not adequate. It was unclear which Ebola patients belonged in which threat categories.